Literature DB >> 2529341

Selective decreases in T cell receptor V beta expression. Decreased expression of specific V beta families is associated with expression of multiple MHC and non-MHC gene products.

M S Vacchio1, R J Hodes.   

Abstract

Previous reports of TCR V beta usage, studying either expression of a single V beta in a wide panel of strains (6, 7, 10, 12, 13), or expression of multiple V beta s in a very limited strain distribution (14, 15), have identified instances of clonal deletion of potentially autoreactive T cells specific for either self E alpha E beta or minor lymphocyte stimulatory (Mls) antigens. The present study has investigated the range of self antigens that can influence V beta usage by evaluating expression of 16 V beta families in 30 strains of mice. It was found that significant decreases in expression occur in at least 8 of the 16 V beta families and that dominant influences on the T cell V beta repertoire are exerted by expression of Mlsa, Mlsc, and MHC gene products. Decreased expressions of V beta 5, -11, -12, and -16 were influenced by MHC gene products. The patterns of decreased expression seen in intra-MHC recombinant strains and strains of different non-MHC background were distinct for V beta 11, -12, and -16, suggesting that different ligands are involved in the deletion of T cells expressing each of these V beta genes. Mice expressing Mlsa show decreased expression of V beta 9 as well as V beta 6. Mlsc mice lacked V beta 3 expression in those strains where the expressed MHC type was compatible with a strongly stimulatory Mlsc phenotype. V beta 7 was strongly influenced by both MHC and non-MHC products that are not yet identified. These results demonstrate that strain-specific decreases of mRNA expression occur in a major portion of the TCR repertoire. Self antigens including Mlsa, Mlsc, and E alpha E beta, as well as additional MHC and non-MHC products, appear to induce these decreases in expression in the process of eliminating self-reactive T cells from the mature T cell pool.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529341      PMCID: PMC2189457          DOI: 10.1084/jem.170.4.1335

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  Correlations between T-cell specificity and the structure of the antigen receptor.

Authors:  P J Fink; L A Matis; D L McElligott; M Bookman; S M Hedrick
Journal:  Nature       Date:  1986 May 15-21       Impact factor: 49.962

2.  T cell recognition of Mlsc. I. Influence of MHC gene products in Mlsc-specific T cell recognition.

Authors:  R Abe; R J Hodes
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

3.  A T cell receptor V beta segment that imparts reactivity to a class II major histocompatibility complex product.

Authors:  J W Kappler; T Wade; J White; E Kushnir; M Blackman; J Bill; N Roehm; P Marrack
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

4.  Positive selection of antigen-specific T cells in thymus by restricting MHC molecules.

Authors:  P Kisielow; H S Teh; H Blüthmann; H von Boehmer
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962

5.  T cells can distinguish between allogeneic major histocompatibility complex products on different cell types.

Authors:  P Marrack; J Kappler
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

6.  Receptor diversity of insulin-specific T cell lines from C57BL (H-2b) mice.

Authors:  D G Spinella; T H Hansen; W D Walsh; M A Behlke; J P Tillinghast; H S Chou; P J Whiteley; J A Kapp; C W Pierce; E M Shevach
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

7.  T cell tolerance by clonal elimination in the thymus.

Authors:  J W Kappler; N Roehm; P Marrack
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

Review 8.  Structure, organization and polymorphism of murine and human T-cell receptor alpha and beta chain gene families.

Authors:  R K Wilson; E Lai; P Concannon; R K Barth; L E Hood
Journal:  Immunol Rev       Date:  1988-01       Impact factor: 12.988

9.  Murine T-cell receptor mutants with deletions of beta-chain variable region genes.

Authors:  M A Behlke; H S Chou; K Huppi; D Y Loh
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  23 in total

1.  Positive selection of Tcrb-V10b+ T cells.

Authors:  K Tomonari; R Hederer; H Hengartner
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Identification of a mouse T-cell antigen receptor alpha-chain polymorphism by a V alpha 3.2 chain-specific monoclonal antibody.

Authors:  Y Utsunomiya; J Bill; E Palmer; O Kanagawa
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  Negative selection of Tcra-V8+CD8+ T cells by MHC class I molecules.

Authors:  K Tomonari
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

4.  Allostimulatory analysis of a newly-defined and widely-distributed Mls superantigen.

Authors:  J J Ryan; H B LeJeune; J J Mond; F D Finkelman
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

5.  Co-segregation of a gene encoding a deletion ligand for Tcrb-V3+ T cells with Mtv-3.

Authors:  S Fairchild; A M Knight; P J Dyson; K Tomonari
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

6.  Genetic analysis of the Mls system. Formal Mls typing of the commonly used inbred strains.

Authors:  R Abe; M Foo-Phillips; R J Hodes
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

7.  Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors.

Authors:  Johannes L Zakrzewski; David Suh; John C Markley; Odette M Smith; Christopher King; Gabrielle L Goldberg; Robert Jenq; Amanda M Holland; Jeremy Grubin; Javier Cabrera-Perez; Renier J Brentjens; Sydney X Lu; Gabrielle Rizzuto; Derek B Sant'Angelo; Isabelle Riviere; Michel Sadelain; Glenn Heller; Juan Carlos Zúñiga-Pflücker; Chen Lu; Marcel R M van den Brink
Journal:  Nat Biotechnol       Date:  2008-03-30       Impact factor: 54.908

8.  T-cell receptor b-V repertoire expression in the absence of an endogenous mouse mammary tumor provirus.

Authors:  R J Hodes; R Abe; D Gallahan; R Callahan
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

Review 9.  Bacterial and viral superantigens: roles in autoimmunity?

Authors:  H Acha-Orbea
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

10.  Immunodominant minor histocompatibility antigens expressed by mouse leukemic cells can serve as effective targets for T cell immunotherapy.

Authors:  S Pion; P Fontaine; C Baron; M Gyger; C Perreault
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.